Acadian Asset Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9,754	Closed	-$181K	–	2250
2024 Q3	$181K	Sell	9,754 -41,374	-81%	-$768K	﹤0.01%	1399
2024 Q2	$850K	Sell	51,128 -17,892	-26%	-$297K	﹤0.01%	1047
2024 Q1	$1.2M	Buy	69,020 +60,334	+695%	+$1.05M	﹤0.01%	795
2023 Q4	$134K	Buy	+8,686	New	+$134K	﹤0.01%	1311